Related Experiment Videos
Guanfacine use in children with attention deficit hyperactivity disorder
1Department of Pharmacy, Mount Sinai Medical Center, New York, NY 10029, USA.
The Annals of Pharmacotherapy
|July 1, 1997
Summary
Guanfacine shows potential for ADHD treatment, especially when other therapies fail or cause side effects. Further research is needed to clarify its role alongside behavioral therapy and stimulants.
Area of Science:
- Neuroscience
- Pharmacology
- Child and Adolescent Psychiatry
Background:
- The efficacy of guanfacine for Attention Deficit Hyperactivity Disorder (ADHD) is not fully established.
- Current treatment guidelines prioritize behavioral modification and stimulant medications.
Purpose of the Study:
- To evaluate the potential role of guanfacine in managing ADHD.
- To identify patient populations that might benefit from guanfacine therapy.
Main Methods:
- Review of existing literature on guanfacine and ADHD treatment.
- Analysis of clinical scenarios where guanfacine might be considered.
Main Results:
- Guanfacine may be a viable option for patients unresponsive or intolerant to other ADHD medications.
- Its use is considered in cases of adverse effects, drug dependence, or emergent motor tics.
- Stimulants remain first-line pharmacotherapy, with guanfacine potentially serving as a second- or third-line option.
Conclusions:
- Guanfacine could be a valuable adjunct or alternative treatment for specific ADHD cases.
- Large-scale, placebo-controlled trials are essential to define guanfacine's definitive role in ADHD management.